Assembly Biosciences, Inc.
Assembly Biosciences, Inc. (ASMB) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
asmb · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Assembly Biosciences, Inc. (ASMB) measures how much investors pay for each dollar of the company's trailing earnings. ASMB's current PE ratio of N/A is calculated by dividing its stock price of $22.55 by its TTM earnings per share of -$0.38.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2008 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Assembly Biosciences, Inc.You ASMB | $358M | N/A | — | -$0.38 |
 Aardvark Therapeutics, Inc. Common Stock AARD | $78M | N/A | — | -$2.64 |
 Arcturus Therapeutics Holdings Inc. ARCT | $202M | N/A | — | -$2.40 |
 Enanta Pharmaceuticals, Inc. ENTA | $257M | N/A | — | -$3.84 |
 Foghorn Therapeutics Inc. FHTX | $218M | N/A | — | -$1.18 |
 Immuneering Corporation IMRX | $143M | N/A | — | -$1.27 |
 Nautilus Biotechnology, Inc. NAUT | $296M | N/A | — | -$0.47 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.55 | — | |
2024-12-31 FY2024 | — | $-6.69 | — | |
2023-12-31 FY2023 | — | $-13.38 | — | |
2022-12-31 FY2022 | — | $-23.08 | — | |
2021-12-31 FY2021 | — | $-36.00 | — | |
2020-12-31 FY2020 | — | $-15.66 | — | |
2019-12-31 FY2019 | — | $-27.83 | — | |
2018-12-31 FY2018 | — | $-39.80 | — | |
2017-12-31 FY2017 | — | $-24.12 | — | |
2016-12-31 FY2016 | — | $-25.69 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Assembly Biosciences, Inc. (ASMB) measures how much investors pay for each dollar of the company's trailing earnings. ASMB's current PE ratio of N/A is calculated by dividing its stock price of $22.55 by its TTM earnings per share of -$0.38.
Frequently asked questions
ASMB pe ratio · 6 questionsASMB's current PE ratio is N/A as of 2026-06-08, based on a stock price of $22.55 and TTM EPS of -$0.38. Data sourced from Financial Modeling Prep via ASMB's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Assembly Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08